Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Photocatalysis: effect of light-activated nanoscale formulations of TiO(2) on Xanthomonas perforans and control of bacterial spot of tomato.

Paret ML, Vallad GE, Averett DR, Jones JB, Olson SM.

Phytopathology. 2013 Mar;103(3):228-36. doi: 10.1094/PHYTO-08-12-0183-R.

2.

Discovery of ANA975: an oral prodrug of the TLR-7 agonist isatoribine.

Xiang AX, Webber SE, Kerr BM, Rueden EJ, Lennox JR, Haley GJ, Wang T, Ng JS, Herbert MR, Clark DL, Banh VN, Li W, Fletcher SP, Steffy KR, Bartkowski DM, Kirkovsky LI, Bauman LA, Averett DR.

Nucleosides Nucleotides Nucleic Acids. 2007;26(6-7):635-40.

PMID:
18066870
3.

The pharmacology of endosomal TLR agonists in viral disease.

Averett DR, Fletcher SP, Li W, Webber SE, Appleman JR.

Biochem Soc Trans. 2007 Dec;35(Pt 6):1468-72. Review.

PMID:
18031247
4.

Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection.

Horsmans Y, Berg T, Desager JP, Mueller T, Schott E, Fletcher SP, Steffy KR, Bauman LA, Kerr BM, Averett DR.

Hepatology. 2005 Sep;42(3):724-31.

PMID:
16116638
5.
6.

Validation of Cdc68p as a novel antifungal target.

Buurman ET, Jiang W, McCoy M, Averett DR, Thompson CM, Wobbe CR.

Arch Microbiol. 2002 Dec;178(6):428-36. Epub 2002 Sep 3.

PMID:
12420162
7.

Regulation of both gene expression and protein stability provides genetically assisted target evaluation (GATE) for microbial target validation.

Buurman ET, Bradley JD, Donnelly CE, Moore JB, Healy JM, Averett DR, Thompson CM, Wobbe CR.

Pharmacogenomics. 2001 May;2(2):95-106. Review.

PMID:
11368749
9.

Monocyclic L-nucleosides with type 1 cytokine-inducing activity.

Ramasamy KS, Tam RC, Bard J, Averett DR.

J Med Chem. 2000 Mar 9;43(5):1019-28.

PMID:
10715165
10.

Inhibition of Borna disease virus replication by ribavirin.

Jordan I, Briese T, Averett DR, Lipkin WI.

J Virol. 1999 Sep;73(9):7903-6.

11.

Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile.

Tam RC, Pai B, Bard J, Lim C, Averett DR, Phan UT, Milovanovic T.

J Hepatol. 1999 Mar;30(3):376-82.

PMID:
10190717
12.

1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity.

Daluge SM, Good SS, Faletto MB, Miller WH, St Clair MH, Boone LR, Tisdale M, Parry NR, Reardon JE, Dornsife RE, Averett DR, Krenitsky TA.

Antimicrob Agents Chemother. 1997 May;41(5):1082-93.

13.
14.

(-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (524W91) inhibits hepatitis B virus replication in primary human hepatocytes.

Condreay LD, Condreay JP, Jansen RW, Paff MT, Averett DR.

Antimicrob Agents Chemother. 1996 Feb;40(2):520-3.

16.

2-Amino-6-methoxypurine arabinoside: an agent for T-cell malignancies.

Lambe CU, Averett DR, Paff MT, Reardon JE, Wilson JG, Krenitsky TA.

Cancer Res. 1995 Aug 1;55(15):3352-6.

17.

[[(Guaninylalkyl)phosphinico]methyl]phosphonic acids. Multisubstrate analogue inhibitors of human erythrocyte purine nucleoside phosphorylase.

Kelley JL, McLean EW, Crouch RC, Averett DR, Tuttle JV.

J Med Chem. 1995 Mar 17;38(6):1005-14.

PMID:
7699692
18.

Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.

Fourel I, Cullen JM, Saputelli J, Aldrich CE, Schaffer P, Averett DR, Pugh J, Mason WS.

J Virol. 1994 Dec;68(12):8321-30.

19.
20.

An enantiospecific synthesis of the human cytomegalovirus antiviral agent [(R)-3-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-4- hydroxybutyl]phosphonic acid.

Chamberlain SD, Biron KK, Dornsife RE, Averett DR, Beauchamp L, Koszalka GW.

J Med Chem. 1994 Apr 29;37(9):1371-7.

PMID:
8176714
21.

Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides.

Van Draanen NA, Tisdale M, Parry NR, Jansen R, Dornsife RE, Tuttle JV, Averett DR, Koszalka GW.

Antimicrob Agents Chemother. 1994 Apr;38(4):868-71.

22.
23.

Novel 6-alkoxypurine 2',3'-dideoxynucleosides as inhibitors of the cytopathic effect of the human immunodeficiency virus.

Burns CL, St Clair MH, Frick LW, Spector T, Averett DR, English ML, Holmes TJ, Krenitsky TA, Koszalka GW.

J Med Chem. 1993 Feb 5;36(3):378-84.

PMID:
8426365
24.

Anabolic pathway of 6-methoxypurine arabinoside in cells infected with varicella-zoster virus.

de Miranda P, Burnette TC, Biron KK, Miller RL, Averett DR, Krenitsky TA.

Antimicrob Agents Chemother. 1991 Oct;35(10):2121-4.

25.

6-N-substituted derivatives of adenine arabinoside as selective inhibitors of varicella-zoster virus.

Koszalka GW, Averett DR, Fyfe JA, Roberts GB, Spector T, Biron K, Krenitsky TA.

Antimicrob Agents Chemother. 1991 Jul;35(7):1437-43.

26.

6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus.

Averett DR, Koszalka GW, Fyfe JA, Roberts GB, Purifoy DJ, Krenitsky TA.

Antimicrob Agents Chemother. 1991 May;35(5):851-7.

27.
29.

Anti-HIV compound assessment by two novel high capacity assays.

Averett DR.

J Virol Methods. 1989 Mar;23(3):263-76.

PMID:
2497128
30.
31.

Ribonucleotide reductase induced by varicella zoster virus. Characterization, and potentiation of acyclovir by its inhibition.

Spector T, Stonehuerner JG, Biron KK, Averett DR.

Biochem Pharmacol. 1987 Dec 15;36(24):4341-6.

PMID:
2825724
32.

A competitive enzyme-linked immunosorbent assay to quantitate acyclovir and BW B759U in human plasma and urine.

Tadepalli SM, Quinn RP, Averett DR.

Antimicrob Agents Chemother. 1986 Jan;29(1):93-8.

33.

Potentiation of antiherpetic activity of acyclovir by ribonucleotide reductase inhibition.

Spector T, Averett DR, Nelson DJ, Lambe CU, Morrison RW Jr, St Clair MH, Furman PA.

Proc Natl Acad Sci U S A. 1985 Jun;82(12):4254-7.

34.
35.

Species-specific irreversible inhibition of Neisseria gonorrhoeae dihydrofolate reductase by a substituted 2,4-diamino-5-benzylpyrimidine.

Tansik RL, Averett DR, Roth B, Paterson SJ, Stone D, Baccanari DP.

J Biol Chem. 1984 Oct 10;259(19):12299-305.

36.

A simple method to purify ribonucleotide reductase.

Spector T, Averett DR.

Anal Biochem. 1983 Oct 15;134(2):467-70.

PMID:
6316808
37.

Ribonucleotide reductase induced by herpes simplex type 1 virus. Characterization of a distinct enzyme.

Averett DR, Lubbers C, Elion GB, Spector T.

J Biol Chem. 1983 Aug 25;258(16):9831-8.

38.

Dihydrofolate reductase from Neisseria sp.

Averett DR, Roth B, Burchall JJ, Baccanari DP.

Antimicrob Agents Chemother. 1979 Mar;15(3):428-35.

39.

A method for the rapid separation and characterization of biological pyridines.

Averett DR, Tritz GJ.

J Chromatogr Sci. 1976 Jul;14(7):350-3.

PMID:
783180

Supplemental Content

Loading ...
Support Center